Back to Awarded Treatment Trials


Awarded Trial: 05-RC-001-1

Grant ID

05-RC-001-1

Illness

Schizophrenia

Primary Drug/Intervention

Atomoxetine

Primary Dosage

80 mg/day

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Tamminga

Sample Size

60

Duration of Study Period for Each Subject

8 weeks

Outcome Measurements

PANSS, CGI, Barnes Akathisia Scale, Simpson Angus Scales, Cognitive Battery

Results

N/A

Publication

N/A

Link

N/A

PI Name

Carol Tamminga

Degree

MD

Center

Department of Psychiatry

Institution

UT Southwestern Medical Center

Address

5323 Harry Hines Boulevard

City or Town

Dallas

State or Province

TX

Zip or Postal Code

75390

Country

USA

Email Address

carol.tamminga@utsouthwestern.edu